कृपया अन्य खोज का प्रयास करें
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients’ oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Lynn A. Tetrault | 59 | 2015 | Independent Chair of the Board |
Christopher Michael Smith | 60 | 2022 | CEO & Director |
Razelle Kurzrock | - | 2021 | Member of Scientific Advisory Board |
Michael A. Kelly | 67 | 2020 | Independent Director |
Bernard A. Fox | 70 | 2021 | Member of Scientific Advisory Board |
Alison L. Hannah | 63 | 2015 | Member of Scientific Advisory Board & Independent Director |
Bruce K. Crowther | 72 | 2014 | Independent Director |
James R. Downing | - | 2021 | Member of Scientific Advisory Board |
Stephen M. Kanovsky | 61 | 2017 | Independent Director |
Riccardo Dalla-Favera | 72 | 2021 | Member of Scientific Advisory Board |
Anthony P. Zook | 63 | 2023 | Independent Director |
Mark A. Rubin | - | 2021 | Member of Scientific Advisory Board |
Rafael Bejar | 51 | 2023 | Member of Scientific Advisory Board |
David Brian Perez | 65 | 2022 | Independent Director |
Neil Gunn | - | 2023 | Independent Director |
Elizabeth Floegel | - | 2023 | Independent Director |
Tibor Kovacsovics | - | 2023 | Scientific Advisory Board Member |
Steven T. Rosen | - | 2021 | Member of Scientific Advisory Board |
James R. Berenson | - | 2023 | Scientific Advisory Board Member |
John N. Allan | - | 2023 | Scientific Advisory Board Member |
Gail J. Roboz | - | 2023 | Scientific Advisory Board Member |
Hatim Husain | - | 2024 | Scientific Advisory Board Member |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है